Royal Bank of Canada’s Kite Pharma, Inc. KITE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-798,569
Closed -$144M 6419
2017
Q3
$144M Buy
798,569
+43,500
+6% +$7.82M 0.07% 218
2017
Q2
$78.3M Sell
755,069
-162,749
-18% -$16.9M 0.04% 325
2017
Q1
$72M Buy
917,818
+188,778
+26% +$14.8M 0.04% 330
2016
Q4
$32.7M Buy
729,040
+82,649
+13% +$3.71M 0.02% 615
2016
Q3
$36.1M Buy
646,391
+479,185
+287% +$26.8M 0.02% 546
2016
Q2
$8.36M Sell
167,206
-21,691
-11% -$1.08M 0.01% 1297
2016
Q1
$8.67M Buy
188,897
+1,491
+0.8% +$68.5K 0.01% 1249
2015
Q4
$11.5M Buy
187,406
+178,717
+2,057% +$11M 0.01% 1141
2015
Q3
$484K Sell
8,689
-5,811
-40% -$324K ﹤0.01% 3016
2015
Q2
$884K Buy
14,500
+8,675
+149% +$529K ﹤0.01% 2619
2015
Q1
$336K Sell
5,825
-9,166
-61% -$529K ﹤0.01% 3399
2014
Q4
$864K Sell
14,991
-13,809
-48% -$796K ﹤0.01% 2571
2014
Q3
$821K Buy
+28,800
New +$821K ﹤0.01% 2537